<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="properties that have been implicated in their hepatoprotective, anti-inflammatory, and" exact="cancer" post="chemopreventive actions [18]. The influence of these substituents in"/>
 <result pre="effect of 27 xanthone derivatives on the growth of human" exact="cancer" post="cell lines, led to select the naturally-occurring 1,3-dihydroxy-2-methylxanthone (3)"/>
 <result pre="antitumor potential towards neuroblastoma, discovering its potent effect in patient-derived" exact="neuroblastoma" post="cells, both alone and in combination with conventional chemotherapeutics"/>
 <result pre="group, showed improved in vitro growth inhibitory activity against the" exact="breast cancer" post="MCF-7 cell line, if compared with their parent compounds"/>
 <result pre="showed improved in vitro growth inhibitory activity against the breast" exact="cancer" post="MCF-7 cell line, if compared with their parent compounds"/>
 <result pre="decrease in Bcl-xL in K-562 cells. Further studies in K-562" exact="leukemia" post="cells also revealed that 22 can act as a"/>
 <result pre="P-gp inhibitor, pointing out its potential to act in MDR" exact="cancer" post="cells [66]. Additionally, 22 showed promising in vitro growth"/>
 <result pre="pyranoxanthone 22 was shown to exhibit potent antiproliferative activity in" exact="leukemia" post="[86] and breast cell lines [86,87], this hit compound"/>
 <result pre="[88] and the promising growth inhibitory activity of 22 in" exact="cancer" post="cell lines [86,87], this pyranoxanthone as well as other"/>
 <result pre="[106], it is beset with many complications including haemorrhage, thrombocytopenia," exact="osteoporosis" post="and inconsistent patient response, owing to its polyanionic, polymeric"/>
 <result pre="able of decreasing Epsteinâ€&quot;Barr virus (EBV) levels in a Burkitt" exact="lymphoma" post="(BL) [116]. EBV infects more than 90% of the"/>
 <result pre="was recently shown to have a potent inhibitory effect on" exact="glioma" post="cells growth [119]. Acetylated xanthonoside 60 and its parent"/>
 <result pre="Î¼M). Association of acetyl groups with inhibition of growth of" exact="glioma" post="cell lines had been reported in the natural O-acetylated"/>
 <result pre="the mammalian brain, which showed strong inhibition of astroblast and" exact="astrocytoma" post="division and in a previous work of our regarding"/>
 <result pre="cell lines [119]. New formulations and/or drug carriers to fight" exact="glioma" post="growth with this promising xanthone are being studied by"/>
 <result pre="often have low efficiency in the treatment and cure of" exact="cancer" post="due to the acquired or intrinsic resistance of tumor"/>
 <result pre="which thioxanthones were modulating P-gp activity. In this assay, two" exact="chronic myeloid leukemia" post="cell lines were used, a sensitive cell line (K562)"/>
 <result pre="thioxanthones were modulating P-gp activity. In this assay, two chronic" exact="myeloid leukemia" post="cell lines were used, a sensitive cell line (K562)"/>
 <result pre="were modulating P-gp activity. In this assay, two chronic myeloid" exact="leukemia" post="cell lines were used, a sensitive cell line (K562)"/>
 <result pre="(sulphorodamine-B assay) of 27 thioxanthones was performed on K562 (chronic" exact="myeloid leukemia" post="cell line) [170], MCF-7 (breast cancer cell line), NCI-H460"/>
 <result pre="assay) of 27 thioxanthones was performed on K562 (chronic myeloid" exact="leukemia" post="cell line) [170], MCF-7 (breast cancer cell line), NCI-H460"/>
 <result pre="on K562 (chronic myeloid leukemia cell line) [170], MCF-7 (breast" exact="cancer" post="cell line), NCI-H460 (non-small cell lung cancer, NSCLC), and"/>
 <result pre="line) [170], MCF-7 (breast cancer cell line), NCI-H460 (non-small cell" exact="lung cancer," post="NSCLC), and A375-C5 (melanoma cell line) [175]. Concerning the"/>
 <result pre="potential antitumor agent which reached phase II clinical trials for" exact="glioblastoma multiforme" post="[153,176]. Concerning the solid tumor cell lines, two compounds,"/>
 <result pre="using in vitro and mouse xenograft tumor models of non-small-cell" exact="lung carcinoma" post="(NSCLC). It was discovered that 80.HCl caused abnormal cellular"/>
 <result pre="ABCC1), MRP2 (or ABCC2, cMOAT), MRP3 (or ABCC3) and the" exact="breast cancer" post="associated protein (BCRP or ABCG2, MXR) [179]. Undoubtedly, a"/>
 <result pre="MRP2 (or ABCC2, cMOAT), MRP3 (or ABCC3) and the breast" exact="cancer" post="associated protein (BCRP or ABCG2, MXR) [179]. Undoubtedly, a"/>
 <result pre="besides being responsible for multidrug resistance of neoplastic cells to" exact="cancer" post="therapy, is also constitutively expressed in many excretory and"/>
 <result pre="nanocapsulesJ. Chromatogr. Sci.20034137137610.1093/chromsci/41.7.37112908954 48.PedroM.CerqueiraF.SousaM.E.l.NascimentoM.S.J.PintoM.Xanthones as inhibitors of growth of human" exact="cancer" post="cell lines and Their effects on the proliferation of"/>
 <result pre="nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human" exact="breast cancer" post="cell linePharm. Dev. Technol.2019241104111410.1080/10837450.2019.163839831269841 71.TeixeiraM.AlonsoM.J.PintoM.M.M.BarbosaC.M.Development and characterization of PLGA"/>
 <result pre="containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast" exact="cancer" post="cell linePharm. Dev. Technol.2019241104111410.1080/10837450.2019.163839831269841 71.TeixeiraM.AlonsoM.J.PintoM.M.M.BarbosaC.M.Development and characterization of PLGA"/>
 <result pre="by Î³-mangostin, a xanthone derivative in mangosteen, in C6 rat" exact="glioma" post="cells11Abbreviations: AA, arachidonic acid; BSA, bovine serum albumin; COX,"/>
 <result pre="of the growth inhibitory action of 4-hydroxytamoxifen in estrogen receptor-positive" exact="breast cancer" post="cell lineMed. Chem. Res.20122155255810.1007/s00044-011-9562-z 88.LeÃ£oM.GomesS.Pedraza-ChaverriJ.MachadoN.SousaE.PintoM.IngaA.PereiraC.SaraivaL.Î±-Mangostin and Gambogic Acid as"/>
 <result pre="the growth inhibitory action of 4-hydroxytamoxifen in estrogen receptor-positive breast" exact="cancer" post="cell lineMed. Chem. Res.20122155255810.1007/s00044-011-9562-z 88.LeÃ£oM.GomesS.Pedraza-ChaverriJ.MachadoN.SousaE.PintoM.IngaA.PereiraC.SaraivaL.Î±-Mangostin and Gambogic Acid as"/>
 <result pre="of p53-mdm2 InteractionWO/2013/105037722013 91.LiuJ.ZhouF.ZhangL.WangH.ZhangJ.ZhangC.JiangZ.LiY.LiuZ.ChenH.DMXAA-pyranoxanthone hybrids enhance inhibition activities against human" exact="cancer" post="cells with multi-target functionsEur. J. Med. Chem.20181431768177810.1016/j.ejmech.2017.10.07429129511 92.PaivaA.M.PintoR.A.TeixeiraM.BarbosaC.M.LimaR.T.VasconcelosM.H.SousaE.PintoM.Development of"/>
 <result pre="profile of compounds with inhibitory activity against hematin aggregation in" exact="malaria" post="parasiteBioorg. Med. Chem.2004123313332110.1016/j.bmc.2004.03.06015158799 103.PortelaC.AfonsoC.M.M.PintoM.M.M.RamosM.J.Receptorâ€&quot;drug association studies in the inhibition"/>
</results>
